ACLX
Price
$69.39
Change
-$0.86 (-1.22%)
Updated
Aug 29 closing price
Capitalization
3.85B
79 days until earnings call
KYMR
Price
$41.20
Change
-$0.55 (-1.32%)
Updated
Aug 29 closing price
Capitalization
2.95B
61 days until earnings call
Interact to see
Advertisement

ACLX vs KYMR

Header iconACLX vs KYMR Comparison
Open Charts ACLX vs KYMRBanner chart's image
Arcellx
Price$69.39
Change-$0.86 (-1.22%)
Volume$518.76K
Capitalization3.85B
Kymera Therapeutics
Price$41.20
Change-$0.55 (-1.32%)
Volume$596.3K
Capitalization2.95B
ACLX vs KYMR Comparison Chart in %
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. KYMR commentary
Aug 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Buy and KYMR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 31, 2025
Stock price -- (ACLX: $69.39 vs. KYMR: $41.20)
Brand notoriety: ACLX and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 96% vs. KYMR: 84%
Market capitalization -- ACLX: $3.85B vs. KYMR: $2.95B
ACLX [@Biotechnology] is valued at $3.85B. KYMR’s [@Biotechnology] market capitalization is $2.95B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, KYMR is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 5 TA indicator(s) are bullish while KYMR’s TA Score has 5 bullish TA indicator(s).

  • ACLX’s TA Score: 5 bullish, 3 bearish.
  • KYMR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ACLX is a better buy in the short-term than KYMR.

Price Growth

ACLX (@Biotechnology) experienced а -2.65% price change this week, while KYMR (@Biotechnology) price change was -6.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.70%. For the same industry, the average monthly price growth was +20.57%, and the average quarterly price growth was +29.45%.

Reported Earning Dates

ACLX is expected to report earnings on Nov 17, 2025.

KYMR is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (-0.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($3.85B) has a higher market cap than KYMR($2.95B). KYMR YTD gains are higher at: 2.411 vs. ACLX (-9.519). ACLX has higher annual earnings (EBITDA): -179.78M vs. KYMR (-267.03M). KYMR has more cash in the bank: 665M vs. ACLX (453M). ACLX has less debt than KYMR: ACLX (52.5M) vs KYMR (85.7M). ACLX has higher revenues than KYMR: ACLX (57M) vs KYMR (44.7M).
ACLXKYMRACLX / KYMR
Capitalization3.85B2.95B131%
EBITDA-179.78M-267.03M67%
Gain YTD-9.5192.411-395%
P/E RatioN/AN/A-
Revenue57M44.7M128%
Total Cash453M665M68%
Total Debt52.5M85.7M61%
TECHNICAL ANALYSIS
Technical Analysis
ACLXKYMR
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 16 days ago
87%
Bullish Trend 9 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
78%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FKDNX201.41N/A
N/A
Franklin DynaTech A
TAAGX13.26N/A
N/A
Timothy Plan Small/Mid Cap Growth Cl A
SIBLX30.08N/A
N/A
Touchstone Balanced Y
PSGRX74.93N/A
N/A
Putnam Small Cap Growth R
HNCFX20.22N/A
N/A
Hartford International Growth F

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been closely correlated with NRIX. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-1.32%
NRIX - KYMR
68%
Closely correlated
-0.74%
VERA - KYMR
59%
Loosely correlated
-2.92%
CGON - KYMR
56%
Loosely correlated
+0.39%
LYRA - KYMR
53%
Loosely correlated
-0.71%
IDYA - KYMR
53%
Loosely correlated
-1.52%
More